GeneproDX
21 September 2018
GeneproDX is a molecular diagnostics company that will comercialize ThyroidPrint®, a gene signature for improved diagnostic accuracy of thyroid fine needle aspiration cytology.
You may be interested in...
-
Nominations Open for 2025 LAVCA Women Investors in Private Capital; New LAVCA Q3 Industry Data; Vinci Partners Acquires Controlling Stake in Outback’s Brazilian Operations
-
Allianz X Leads USD300m Series E for Argentina’s Ualá
Allianz X led a USD300m Series E for Argentina-based fintech Ualá, with participation...
-
Vinci Partners Acquires Controlling Stake in Outback’s Brazilian Operations
Vinci Partners acquired a controlling stake in Outback owner Bloomin’ Brands‘...
-
Call for Nominations: Top & Emerging Women Investors in LatAm 2025